Passage Bio

1 follower

‌

Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).

Industries

Biotechnology

Headquarters

Philadelphia, United States

Employees

51-200

Links

Org chart

William Chou

President & CEO

Collapse

James M. Wilson

Chief Scientific Advisor

Edgar B. Cale

General Counsel & Corporate Secretary

Samiah Al-Zaidy

VP, Clinical Development

Eden Fucci

VP, Manufacturing Operations

Tiffini Voss

VP, Clinical Development

Stuart Henderson

VP, Corporate Development & Investor Relations

Sue Browne

VP, Biology

Steve Krausert

Vice President, Supply Chain & Planning

Derek Kichula

Senior Director, Engineering & General Manager

Karl Whitney

Senior Vice President, Global Regulatory Affairs

Samiah A. A.

Vice President Clinical Development

Pamela H.

Vice President Clinical Operations

Chelsea Difebbo Ortiz

Executive Director, Patient Advocacy

Glen Kerker II

Director, Regulatory Operations

Board & advisors

Director

Chairwoman

Director

Director

Director

Director

Teams

Leadership Team

12 people · 0 jobs

Scientific Research and Development

8 people · 0 jobs

Clinical Operations and Quality Assurance

7 people · 0 jobs

Finance and Administrative Support

4 people · 0 jobs

Offices

HQ
15 positions, 0 job posts
JC
+11

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

157 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

Explore companies